EI- Nile Co. for Pharmaceuticals and Chemical Industries (EGX:NIPH)

EGX:NIPH Financials Overview

Financials in millions EGP. Fiscal year is July - June.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue Revenue Growth	2,239	1,290	1,143	1,005	876.78	755.51
Revenue Growth	113.77%	12.86%	13.66%	14.65%	16.05%	-7.02%
Gross Profit Gross Profit Growth	702.99	407.83	252.44	272.05	222.57	201.08
Operating Income Operating Income Growth	568.26	279.33	143.52	162.76	125.44	95.6
Net Income Net Income Growth	240.13	125.73	90.23	119.21	89.67	64.42
Earnings Per Share EPS Growth	4.80	4.19	8.91	11.77	8.86	6.36
EPS Growth	55.76%	-52.97%	-24.32%	32.94%	39.20%	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Investments Cash & Investments Growth	21.2	21.36	34.35	21.44	53.57	109.61
Total Debt Total Debt Growth	1,354	988.73	575.28	212.49	79.78	43.39
Net Cash (Debt) Net Cash Growth	-1,332	-967.37	-540.93	-191.06	-26.21	66.22
Net Cash Growth	-	-	-	-	-	49.87%
Net Cash Per Share Net Cash Per Share Growth	-26.65	-32.25	-53.42	-18.87	-2.59	6.54

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating Cash Flow Operating Cash Flow Growth	-294.47	0.93	264.11	-256.43	4.91	79.47
Capital Expenditures CapEx Growth	-423.17	-473.89	-419.69	-27.63	-48.74	-4.38
Free Cash Flow Free Cash Flow Growth	-717.63	-472.96	-155.57	-284.07	-43.83	75.09
Free Cash Flow Growth	-	-	-	-	-	68.64%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Gross Margin	31.39%	31.62%	22.09%	27.06%	25.39%	26.62%
Operating Margin	25.38%	21.66%	12.56%	16.19%	14.31%	12.65%
Pretax Margin	13.88%	12.66%	9.47%	14.47%	13.26%	10.93%
Profit Margin	10.72%	9.75%	7.90%	11.86%	10.23%	8.53%
FCF Margin	-32.05%	-36.68%	-13.62%	-28.26%	-5.00%	9.94%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 5, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Dividend Per Share Dividend Per Share Growth	2.000	2.000	3.710	5.000	2.970	2.000
Dividend Per Share Growth	-46.09%	-46.09%	-25.80%	68.35%	48.50%	-
Dividend Yield	0.76%	6.25%	22.04%	55.09%	40.27%	29.57%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 5, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
PE Ratio	56.43	11.65	7.75	3.40	4.00	5.50
P/FCF Ratio	-	-	-	-	-	4.72
PS Ratio	6.05	1.14	0.61	0.40	0.41	0.47

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error